THE Generic and Biosimilar Medicines Association (GBMA) has appointed Dr Stephen Jenkins, Director of Government and Corporate Affairs APAC at Teva Pharmaceuticals, to its Board of Directors.

Dr Jenkins brings over 20 years of leadership experience in the pharmaceutical sector and a proven track record in shaping effective healthcare policy.

His insights will be valued as GBMA continues its work to strengthen the PBS sustainability and improve medicine accessibility at a time of intensifying global market pressures and supply chain challenges, the peak body said.

GBMA Independent Chair, Professor Jane Halton, welcomed the appointment, and said, “Stephen’s strategic expertise and global perspective will be an asset to the Board as we continue to advocate for policies that safeguard continuity of supply for Australian patients.”

Dr Jenkins said he was honoured to join the GBMA Board.

“The work GBMA does to secure timely and reliable access to medicines is vital for Australian patients,” he said.

“I look forward to contributing to these efforts and collaborating with government and industry to maintain a sustainable PBS.”

The post GBMA appoints Teva’s Dr Stephen Jenkins to Board of Directors appeared first on Pharmacy Daily.